论文信息 - Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data - 字舞流文

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

J. Schölmerich | S. Nikolaus | W. Sandborn | J. Panés | J. Colombel | R. Bloomfield | S. Schreiber